# Anti-inflammatory Drug Algorithm for COVID-19 Home Treatment

> **NCT05249790** · PHASE3 · WITHDRAWN · sponsor: **Mario Negri Institute for Pharmacological Research**

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Recommended treatment schedule
- **DRUG:** Usual care

## Key facts

- **NCT ID:** NCT05249790
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-02-24
- **Primary completion:** 2022-02-24
- **Final completion:** 2022-02-24
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** authorization denied
- **Last updated:** 2024-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05249790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05249790, "Anti-inflammatory Drug Algorithm for COVID-19 Home Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05249790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*